| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/31/2013 | EP2620434A1 Crystals of substituted cycloalkene derivatives |
| 07/31/2013 | EP2620433A1 Substituted amide compound |
| 07/31/2013 | EP2620431A1 Novel crystals of substituted phenylalkanoic acid and production process |
| 07/31/2013 | EP2620145A2 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ |
| 07/31/2013 | EP1476185B1 Antibodies to cd40 |
| 07/31/2013 | CN103228653A Substituted polycyclic carbamoyl pyridone derivative prodrug |
| 07/31/2013 | CN103224934A Short interfering ribonucleic acid (siRNA) for oral administration |
| 07/31/2013 | CN103224562A Epitope regions of a thyrotrophin (TSH) receptor, and antibodies thereto |
| 07/31/2013 | CN103223175A Scar and tissue fibration resistant oligomeric double-stranded nucleotide medicine and its application |
| 07/31/2013 | CN103223123A Perimenopausal syndrome treatment drug composition, preparation method and uses thereof |
| 07/31/2013 | CN103223101A Traditional Chinese medicine for treating thyroid cyst |
| 07/31/2013 | CN103223035A Medicine for raising body temperature |
| 07/31/2013 | CN102631624B Chinese herba external lotion for treating swelling of upper limb of affected side after breast cancer surgery |
| 07/31/2013 | CN101619033B Modafinil polymorphic forms |
| 07/31/2013 | CN101602653B Halogenated hydroxyl aromatic methane compounds, preparation method and use thereof |
| 07/31/2013 | CN101404995B Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 07/30/2013 | USRE44399 One dose vaccination with Mycoplasma hyopneumoniae |
| 07/30/2013 | CA2610638C Use of agomelatine to obtain drugs intended for the treatment of smith-magenis syndrome |
| 07/30/2013 | CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity |
| 07/30/2013 | CA2480079C Antiangiogenic active immunotherapy |
| 07/25/2013 | WO2013108921A1 Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof |
| 07/25/2013 | WO2013108869A1 Therapeutic or prophylactic agent for cancer |
| 07/25/2013 | WO2013108857A1 Heterocyclic amide derivative and pharmaceutical product containing same |
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013108809A1 3,5-disubstituted alkynylbenzene compound and salt thereof |
| 07/25/2013 | WO2013108800A1 Substituted phenylazole derivative |
| 07/25/2013 | WO2013108780A1 AMYLOID β-PROTEIN-SPECIFIC PRODUCTION-INHIBITING POLYPEPTIDE |
| 07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
| 07/25/2013 | WO2013107164A1 Novel indoleamine-2, 3-dioxygenase inhibitor, preparation method therefor and uses thereof |
| 07/25/2013 | WO2013045959A3 Camphene reduces plasma cholesterol and triglycerides |
| 07/25/2013 | US20130190495 Compositions and methods of treatment of cancer |
| 07/25/2013 | US20130190407 Calcium receptor-active molecules |
| 07/25/2013 | US20130190247 Peptide antagonists of zonulin and methods for use of the same |
| 07/25/2013 | US20130190225 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment |
| 07/25/2013 | US20130189678 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/25/2013 | CA2854093A1 3,5-disubstituted alkynylbenzene compound and salt thereof |
| 07/24/2013 | EP2617722A1 Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/24/2013 | EP2617423A1 Purine derivatives for the treatment of cystic diseases |
| 07/24/2013 | EP2617416A1 Cancer heat therapy-enhancing agent |
| 07/24/2013 | EP2616431A1 Novel cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof |
| 07/24/2013 | EP2616081A1 Method for mobilizing stem and/or progenitor cells |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN1795196B Use of amide in preparing compound agent for repairing corneal sensitivity |
| 07/24/2013 | CN1462191B Treatment of ocute coronary syndrome with GLP-1 |
| 07/24/2013 | CN103221412A (Aza)indolizine derivative and pharmaceutical use thereof |
| 07/24/2013 | CN103221405A Substituted pyridine compound |
| 07/24/2013 | CN103221066A Sustained-release pharmaceutical composition |
| 07/24/2013 | CN103221060A Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 07/24/2013 | CN103221043A Inhibitors of ERK for developmental disorders of neuronal connectivity |
| 07/24/2013 | CN103221041A Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders |
| 07/24/2013 | CN103215234A Adenovirus with zinc finger nuclease expression element and donor DNA, and construction method and application |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103211980A Traditional Chinese medicine composition for treatment of yin deficiency and yang excess |
| 07/24/2013 | CN103211895A Prescription for treating snoring and tooth-grinding when sleeping |
| 07/24/2013 | CN103211766A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/24/2013 | CN101652147B Combined use of dipeptidyl peptidase IV inhibitor compound and sweetener |
| 07/24/2013 | CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492353 Antiaging composition |
| 07/23/2013 | US8492330 Formulation comprising GLP-1 |
| 07/23/2013 | US8492111 Arylalkylamine compound and process for preparing the same |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2496005C Use of botulinum toxin for the treatment of fine wrinkles and pore size |
| 07/23/2013 | CA2357950C Therapeutic phosphodiesterase inhibitors |
| 07/18/2013 | WO2013105665A1 Collagen structure, and method for producing collagen structure |
| 07/18/2013 | WO2013105608A1 P2x4 receptor antagonist |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184281 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 07/18/2013 | US20130184231 Organ arrest, protection and preservation |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/17/2013 | EP2615096A1 Quinoxaline compound |
| 07/17/2013 | EP2615088A1 Composition, synthesis and use of new substituted pyran and pterin compounds |
| 07/17/2013 | EP2615085A1 Pyridyl derivatives as CFTR modulators |
| 07/17/2013 | EP2615084A1 Prostaglandin d synthase inhibitory piperidine compounds |
| 07/17/2013 | EP2614813A1 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent |
| 07/17/2013 | EP2613794A1 Treatment of constipation-predominant irritable bowel syndrome |
| 07/17/2013 | CN103209989A Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 07/17/2013 | CN103209981A Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/17/2013 | CN103209968A Pluripotent stem cell cardiomyocyte differentiation-promoting agent |
| 07/17/2013 | CN103204920A Novel epidermal growth factors and applications for same |
| 07/17/2013 | CN103202999A Modified peach pit flatus-smoothing oral liquid used for operative complications and preparation method thereof |
| 07/17/2013 | CN102379887B Cardiovascular disease treating medicament and preparation method and application thereof |
| 07/17/2013 | CN102361638B Transdermal preparation |
| 07/17/2013 | CN102172351B Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 07/17/2013 | CN102030771B Compound used as transient receptor potential vanilloid (TRPV1) blocker, medicinal composition and pharmaceutical application thereof |
| 07/17/2013 | CN101985037B Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 07/17/2013 | CN101910182B Antitumor agent |
| 07/17/2013 | CN101573446B Aptamer against midkine and use thereof |
| 07/17/2013 | CN101412744B Anti-angiogenic compositions and methods of use thereof |
| 07/17/2013 | CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/16/2013 | US8487009 1,2-diphenylethene derivatives for treatment of immune diseases |
| 07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486923 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486452 Stabilized tolterodine tartrate formulations |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |